EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC

Condition:   Head and Neck Squamous Cell Carcinoma Intervention:   Drug: HPV E6-specific TCR-T cell with anti-PD1 auto-secreted element Sponsors:   Xinqiao Hospital of Chongqing;   TCRCure Biopharma Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials